{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:59:11Z","timestamp":1791572351076,"version":"4.3.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004462","name":"Consiglio Nazionale delle Ricerche","doi-asserted-by":"publisher","award":["Research Project Aging: molecular"],"award-info":[{"award-number":["Research Project Aging: molecular"]}],"id":[{"id":"10.13039\/501100004462","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004462","name":"Consiglio Nazionale delle Ricerche","doi-asserted-by":"publisher","award":["technological innovations for improving the health of the elderly (Prot. MIUR 2867 25.11.2011)."],"award-info":[{"award-number":["technological innovations for improving the health of the elderly (Prot. MIUR 2867 25.11.2011)."]}],"id":[{"id":"10.13039\/501100004462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s40520-019-01359-4","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T13:03:36Z","timestamp":1570107816000},"page":"823-834","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Acetylcholinesterase inhibitors targeting the cholinergic anti-inflammatory pathway: a new therapeutic perspective in aging-related disorders"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5396-5429","authenticated-orcid":false,"given":"Roberta","family":"Benfante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5971-1515","authenticated-orcid":false,"given":"Simona","family":"Di Lascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9758-2649","authenticated-orcid":false,"given":"Silvia","family":"Cardani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9668-3103","authenticated-orcid":false,"given":"Diego","family":"Fornasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,3]]},"reference":[{"key":"1359_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/npp.2016.185","volume":"42","author":"A Niraula","year":"2017","unstructured":"Niraula A, Sheridan JF, Godbout JP (2017) Microglia priming with aging and stress. Neuropsychopharmacology 42:318\u2013333. https:\/\/doi.org\/10.1038\/npp.2016.185","journal-title":"Neuropsychopharmacology"},{"key":"1359_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","volume":"221","author":"R Schliebs","year":"2011","unstructured":"Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221:555\u2013563. https:\/\/doi.org\/10.1016\/j.bbr.2010.11.058","journal-title":"Behav Brain Res"},{"key":"1359_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14:388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"key":"1359_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.neuropharm.2015.02.006","volume":"96","author":"ML Sinkus","year":"2015","unstructured":"Sinkus ML, Graw S, Freedman R (2015) The human CHRNA7 and CHRFAM7A genes: a review of the genetics, regulation, and function. Neuropharmacology 96:274\u2013288. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.02.006","journal-title":"Neuropharmacology"},{"key":"1359_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nature01321","volume":"420","author":"KJ Tracey","year":"2002","unstructured":"Tracey KJ (2002) The inflammatory reflex. Nature 420:853. https:\/\/doi.org\/10.1038\/nature01321","journal-title":"Nature"},{"key":"1359_CR6","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.2174\/1381612822666160215154218","volume":"22","author":"A Confaloni","year":"2016","unstructured":"Confaloni A, Tosto G, Tata AM (2016) Promising therapies for Alzheimer\u2019s disease. Curr Pharm Des 22:2050\u20132056","journal-title":"Curr Pharm Des"},{"key":"1359_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/ntr\/nty116","volume":"21","author":"JL Hoskin","year":"2019","unstructured":"Hoskin JL, Al-Hasan Y, Sabbagh MN (2019) Nicotinic acetylcholine receptor agonists for the treatment of Alzheimer\u2019s dementia: an update. Nicotine Tob Res 21:370\u2013376. https:\/\/doi.org\/10.1093\/ntr\/nty116","journal-title":"Nicotine Tob Res"},{"key":"1359_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12031-009-9236-1","volume":"40","author":"A Akaike","year":"2010","unstructured":"Akaike A, Takada-Takatori Y, Kume T et al (2010) Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection. J Mol Neurosci 40:211\u2013216. https:\/\/doi.org\/10.1007\/s12031-009-9236-1","journal-title":"J Mol Neurosci"},{"key":"1359_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2008.06.011","volume":"23","author":"VA Pavlov","year":"2009","unstructured":"Pavlov VA, Parrish WR, Rosas-Ballina M et al (2009) Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun 23:41\u201345. https:\/\/doi.org\/10.1016\/j.bbi.2008.06.011","journal-title":"Brain Behav Immun"},{"key":"1359_CR10","doi-asserted-by":"publisher","first-page":"9809","DOI":"10.3390\/ijms15069809","volume":"15","author":"M Pohanka","year":"2014","unstructured":"Pohanka M (2014) Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity. Int J Mol Sci 15:9809\u20139825. https:\/\/doi.org\/10.3390\/ijms15069809","journal-title":"Int J Mol Sci"},{"key":"1359_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jneuroim.2003.11.003","volume":"148","author":"M Reale","year":"2004","unstructured":"Reale M, Iarlori C, Gambi F et al (2004) Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. J Neuroimmunol 148:162\u2013171. https:\/\/doi.org\/10.1016\/j.jneuroim.2003.11.003","journal-title":"J Neuroimmunol"},{"key":"1359_CR12","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/archneur.64.12.1771","volume":"64","author":"SE Counts","year":"2007","unstructured":"Counts SE, He B, Che S et al (2007) Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease. Arch Neurol 64:1771\u20131776. https:\/\/doi.org\/10.1001\/archneur.64.12.1771","journal-title":"Arch Neurol"},{"key":"1359_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jmg.2007.052704","volume":"45","author":"R Carson","year":"2008","unstructured":"Carson R, Craig D, McGuinness B et al (2008) Alpha7 nicotinic acetylcholine receptor gene and reduced risk of Alzheimer\u2019s disease. J Med Genet 45:244\u2013248. https:\/\/doi.org\/10.1136\/jmg.2007.052704","journal-title":"J Med Genet"},{"key":"1359_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000082661","volume":"19","author":"LW Chu","year":"2005","unstructured":"Chu LW, Ma ES, Lam KK et al (2005) Increased alpha 7 nicotinic acetylcholine receptor protein levels in Alzheimer\u2019s disease patients. Dement Geriatr Cogn Disord 19:106\u2013112. https:\/\/doi.org\/10.1159\/000082661","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1359_CR15","doi-asserted-by":"publisher","first-page":"e84059","DOI":"10.1371\/journal.pone.0084059","volume":"8","author":"PH Weng","year":"2013","unstructured":"Weng PH, Chen JH, Chen TF et al (2013) CHRNA7 polymorphisms and response to cholinesterase inhibitors in Alzheimer\u2019s disease. PLoS ONE 8:e84059. https:\/\/doi.org\/10.1371\/journal.pone.0084059","journal-title":"PLoS ONE"},{"key":"1359_CR16","doi-asserted-by":"publisher","first-page":"10707","DOI":"10.1074\/jbc.RA117.001698","volume":"293","author":"M Lasala","year":"2018","unstructured":"Lasala M, Corradi J, Bruzzone A et al (2018) A human-specific, truncated alpha7 nicotinic receptor subunit assembles with full-length alpha7 and forms functional receptors with different stoichiometries. J Biol Chem 293:10707\u201310717. https:\/\/doi.org\/10.1074\/jbc.RA117.001698","journal-title":"J Biol Chem"},{"key":"1359_CR17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1074\/jbc.M110.180067","volume":"286","author":"AM de Lucas-Cerrillo","year":"2011","unstructured":"de Lucas-Cerrillo AM, Maldifassi MC, Arnalich F et al (2011) Function of partially duplicated human \u03b177 nicotinic receptor subunit CHRFAM7A gene: potential implications for the cholinergic anti-inflammatory response. J Biol Chem 286:594\u2013606. https:\/\/doi.org\/10.1074\/jbc.M110.180067","journal-title":"J Biol Chem"},{"key":"1359_CR18","doi-asserted-by":"publisher","first-page":"7932","DOI":"10.1073\/pnas.1821853116","volume":"116","author":"TW Costantini","year":"2019","unstructured":"Costantini TW, Chan TW, Cohen O et al (2019) Uniquely human CHRFAM7A gene increases the hematopoietic stem cell reservoir in mice and amplifies their inflammatory response. Proc Natl Acad Sci USA 116:7932\u20137940. https:\/\/doi.org\/10.1073\/pnas.1821853116","journal-title":"Proc Natl Acad Sci USA"},{"key":"1359_CR19","doi-asserted-by":"publisher","first-page":"13874","DOI":"10.1074\/jbc.RA118.003443","volume":"293","author":"MC Maldifassi","year":"2018","unstructured":"Maldifassi MC, Mart\u00edn-S\u00e1nchez C, Atienza G et al (2018) Interaction of the \u03b17-nicotinic subunit with its human-specific duplicated dup\u03b17 isoform in mammalian cells: relevance in human inflammatory responses. J Biol Chem 293:13874\u201313888. https:\/\/doi.org\/10.1074\/jbc.RA118.003443","journal-title":"J Biol Chem"},{"key":"1359_CR20","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1096\/fj.14-268037","volume":"29","author":"X Dang","year":"2015","unstructured":"Dang X, Eliceiri BP, Baird A et al (2015) CHRFAM7A: a human-specific \u03b17-nicotinic acetylcholine receptor gene shows differential responsiveness of human intestinal epithelial cells to LPS. FASEB J 29:2292\u20132302. https:\/\/doi.org\/10.1096\/fj.14-268037","journal-title":"FASEB J"},{"key":"1359_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/35013070","volume":"405","author":"LV Borovikova","year":"2000","unstructured":"Borovikova LV, Ivanova S, Zhang M et al (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458\u2013462. https:\/\/doi.org\/10.1038\/35013070","journal-title":"Nature"},{"key":"1359_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.05.002","volume":"179","author":"DB Hoover","year":"2017","unstructured":"Hoover DB (2017) Cholinergic modulation of the immune system presents new approaches for treating inflammation. Pharmacol Ther 179:1\u201316. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.05.002","journal-title":"Pharmacol Ther"},{"key":"1359_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-642-23274-9_1","volume":"208","author":"RM Eglen","year":"2012","unstructured":"Eglen RM (2012) Overview of muscarinic receptor subtypes. Handb Exp Pharmacol 208:3\u201328. https:\/\/doi.org\/10.1007\/978-3-642-23274-9_1","journal-title":"Handb Exp Pharmacol"},{"key":"1359_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1152\/physrev.00015.2008","volume":"89","author":"EX Albuquerque","year":"2009","unstructured":"Albuquerque EX, Pereira EF, Alkondon M et al (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89:73\u2013120. https:\/\/doi.org\/10.1152\/physrev.00015.2008","journal-title":"Physiol Rev"},{"key":"1359_CR25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/1570159X15666170912110450","volume":"16","author":"M Zoli","year":"2018","unstructured":"Zoli M, Pucci S, Vilella A et al (2018) Neuronal and extraneuronal nicotinic acetylcholine receptors. Curr Neuropharmacol 16:338\u2013349. https:\/\/doi.org\/10.2174\/1570159X15666170912110450","journal-title":"Curr Neuropharmacol"},{"key":"1359_CR26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature01339","volume":"421","author":"H Wang","year":"2003","unstructured":"Wang H, Yu M, Ochani M et al (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421:384\u2013388. https:\/\/doi.org\/10.1038\/nature01339","journal-title":"Nature"},{"key":"1359_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jneuroim.2019.01.008","volume":"327","author":"CC Eduardo","year":"2019","unstructured":"Eduardo CC, Alejandra TG, Guadalupe DKJ (2019) Modulation of the extraneuronal cholinergic system on main innate response leukocytes. J Neuroimmunol 327:22\u201335. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.01.008","journal-title":"J Neuroimmunol"},{"key":"1359_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.tips.2018.01.002","volume":"39","author":"N Kabbani","year":"2018","unstructured":"Kabbani N, Nichols RA (2018) Beyond the channel: metabotropic signaling by nicotinic receptors. Trends Pharmacol Sci 39:354\u2013366. https:\/\/doi.org\/10.1016\/j.tips.2018.01.002","journal-title":"Trends Pharmacol Sci"},{"key":"1359_CR29","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0896-6273(01)00516-5","volume":"32","author":"KT Chang","year":"2001","unstructured":"Chang KT, Berg DK (2001) Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons. Neuron 32:855\u2013865","journal-title":"Neuron"},{"key":"1359_CR30","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/neu.10116","volume":"53","author":"DK Berg","year":"2002","unstructured":"Berg DK, Conroy WG (2002) Nicotinic alpha 7 receptors: synaptic options and downstream signaling in neurons. J Neurobiol 53:512\u2013523. https:\/\/doi.org\/10.1002\/neu.10116","journal-title":"J Neurobiol"},{"key":"1359_CR31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/neu.10114","volume":"53","author":"G Sharma","year":"2002","unstructured":"Sharma G, Vijayaraghavan S (2002) Nicotinic receptor signaling in nonexcitable cells. J Neurobiol 53:524\u2013534. https:\/\/doi.org\/10.1002\/neu.10114","journal-title":"J Neurobiol"},{"key":"1359_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1471-4159.2004.02347.x","volume":"89","author":"RD Shytle","year":"2004","unstructured":"Shytle RD, Mori T, Townsend K et al (2004) Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem 89:337\u2013343. https:\/\/doi.org\/10.1046\/j.1471-4159.2004.02347.x","journal-title":"J Neurochem"},{"key":"1359_CR33","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/2211-5463.12270","volume":"7","author":"JR King","year":"2017","unstructured":"King JR, Gillevet TC, Kabbani N (2017) A G protein-coupled alpha7 nicotinic receptor regulates signaling and TNF-alpha release in microglia. FEBS Open Bio 7:1350\u20131361. https:\/\/doi.org\/10.1002\/2211-5463.12270","journal-title":"FEBS Open Bio"},{"key":"1359_CR34","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/jnr.20850","volume":"83","author":"T Suzuki","year":"2006","unstructured":"Suzuki T, Hide I, Matsubara A et al (2006) Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C\/IP3 pathway and modulate the cell activation toward a neuroprotective role. J Neurosci Res 83:1461\u20131470. https:\/\/doi.org\/10.1002\/jnr.20850","journal-title":"J Neurosci Res"},{"key":"1359_CR35","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3389\/fimmu.2018.01604","volume":"9","author":"K Richter","year":"2018","unstructured":"Richter K, Sagawe S, Hecker A et al (2018) C-reactive protein stimulates nicotinic acetylcholine receptors to control ATP-mediated monocytic inflammasome activation. Front Immunol 9:1604. https:\/\/doi.org\/10.3389\/fimmu.2018.01604","journal-title":"Front Immunol"},{"key":"1359_CR36","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.4049\/jimmunol.179.5.2889","volume":"179","author":"S Razani-Boroujerdi","year":"2007","unstructured":"Razani-Boroujerdi S, Boyd RT, D\u00e1vila-Garc\u00eda MI et al (2007) T cells express alpha7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca2+ response. J Immunol 179:2889\u20132898. https:\/\/doi.org\/10.4049\/jimmunol.179.5.2889","journal-title":"J Immunol"},{"key":"1359_CR37","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.tips.2015.05.002","volume":"36","author":"C Stokes","year":"2015","unstructured":"Stokes C, Treinin M, Papke RL (2015) Looking below the surface of nicotinic acetylcholine receptors. Trends Pharmacol Sci 36:514\u2013523. https:\/\/doi.org\/10.1016\/j.tips.2015.05.002","journal-title":"Trends Pharmacol Sci"},{"key":"1359_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2008.11.053","volume":"1256","author":"MB Marrero","year":"2009","unstructured":"Marrero MB, Bencherif M (2009) Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB. Brain Res 1256:1\u20137. https:\/\/doi.org\/10.1016\/j.brainres.2008.11.053","journal-title":"Brain Res"},{"key":"1359_CR39","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ni1229","volume":"6","author":"WJ de Jonge","year":"2005","unstructured":"de Jonge WJ, van der Zanden EP, The FO et al (2005) Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6:844\u2013851. https:\/\/doi.org\/10.1038\/ni1229","journal-title":"Nat Immunol"},{"key":"1359_CR40","doi-asserted-by":"publisher","first-page":"44920","DOI":"10.1074\/jbc.M204610200","volume":"277","author":"S Shaw","year":"2002","unstructured":"Shaw S, Bencherif M, Marrero MB (2002) Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid. J Biol Chem 277:44920\u201344924. https:\/\/doi.org\/10.1074\/jbc.M204610200","journal-title":"J Biol Chem"},{"key":"1359_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1365-2249.2006.03169.x","volume":"146","author":"H Yoshikawa","year":"2006","unstructured":"Yoshikawa H, Kurokawa M, Ozaki N et al (2006) Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol 146:116\u2013123. https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03169.x","journal-title":"Clin Exp Immunol"},{"key":"1359_CR42","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12974-017-0967-6","volume":"14","author":"H Patel","year":"2017","unstructured":"Patel H, McIntire J, Ryan S et al (2017) Anti-inflammatory effects of astroglial alpha7 nicotinic acetylcholine receptors are mediated by inhibition of the NF-kappaB pathway and activation of the Nrf2 pathway. J Neuroinflammation 14:192. https:\/\/doi.org\/10.1186\/s12974-017-0967-6","journal-title":"J Neuroinflammation"},{"key":"1359_CR43","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/cr.2013.116","volume":"23","author":"Y Sun","year":"2013","unstructured":"Sun Y, Li Q, Gui H et al (2013) MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell Res 23:1270\u20131283. https:\/\/doi.org\/10.1038\/cr.2013.116","journal-title":"Cell Res"},{"key":"1359_CR44","doi-asserted-by":"publisher","first-page":"e108397","DOI":"10.1371\/journal.pone.0108397","volume":"9","author":"MC Maldifassi","year":"2014","unstructured":"Maldifassi MC, Atienza G, Arnalich F et al (2014) A new IRAK-M-mediated mechanism implicated in the anti-inflammatory effect of nicotine via \u03b17 nicotinic receptors in human macrophages. PLoS ONE 9:e108397. https:\/\/doi.org\/10.1371\/journal.pone.0108397","journal-title":"PLoS ONE"},{"key":"1359_CR45","doi-asserted-by":"publisher","first-page":"37117","DOI":"10.1074\/jbc.M608202200","volume":"281","author":"T Takahashi","year":"2006","unstructured":"Takahashi T, Morrow JD, Wang H et al (2006) Cyclooxygenase-2-derived prostaglandin E(2) directs oocyte maturation by differentially influencing multiple signaling pathways. J Biol Chem 281:37117\u201337129. https:\/\/doi.org\/10.1074\/jbc.M608202200","journal-title":"J Biol Chem"},{"key":"1359_CR46","doi-asserted-by":"publisher","first-page":"636","DOI":"10.2174\/138945012800398928","volume":"13","author":"M Neri","year":"2012","unstructured":"Neri M, Bonassi S, Russo P (2012) Genetic variations in CHRNA7 or CHRFAM7 and susceptibility to dementia. Curr Drug Targets 13:636\u2013643","journal-title":"Curr Drug Targets"},{"key":"1359_CR47","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","volume":"275","author":"HY Wang","year":"2000","unstructured":"Wang HY, Lee DH, D\u2019Andrea MR, Peterson PA, Shank RP, Reitz AB (2000) beta-Amyloid(1\u201342) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer\u2019s disease pathology. J Biol Chem 275:5626\u20135632. https:\/\/doi.org\/10.1074\/jbc.275.8.5626","journal-title":"J Biol Chem"},{"key":"1359_CR48","doi-asserted-by":"publisher","first-page":"8805","DOI":"10.1523\/JNEUROSCI.6159-08.2009","volume":"29","author":"G Dziewczapolski","year":"2009","unstructured":"Dziewczapolski G, Glogowski CM, Masliah E et al (2009) Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer\u2019s disease. J Neurosci 29:8805\u20138815. https:\/\/doi.org\/10.1523\/JNEUROSCI.6159-08.2009","journal-title":"J Neurosci"},{"key":"1359_CR49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0306-4522(01)00460-2","volume":"110","author":"RG Nagele","year":"2002","unstructured":"Nagele RG, D\u2019Andrea MR, Anderson WJ et al (2002) Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer\u2019s disease. Neuroscience 110:199\u2013211","journal-title":"Neuroscience"},{"key":"1359_CR50","doi-asserted-by":"publisher","first-page":"31547","DOI":"10.1074\/jbc.M212532200","volume":"278","author":"HY Wang","year":"2003","unstructured":"Wang HY, Li W, Benedetti NJ et al (2003) Alpha 7 nicotinic acetylcholine receptors mediate beta-amyloid peptide-induced tau protein phosphorylation. J Biol Chem 278:31547\u201331553. https:\/\/doi.org\/10.1074\/jbc.M212532200","journal-title":"J Biol Chem"},{"key":"1359_CR51","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1523\/JNEUROSCI.21-01-j0003.2001","volume":"21","author":"DL Pettit","year":"2001","unstructured":"Pettit DL, Shao Z, Yakel JL (2001) beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J Neurosci 21:120","journal-title":"J Neurosci"},{"key":"1359_CR52","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1460-9568.2007.05636.x","volume":"26","author":"HJ Park","year":"2007","unstructured":"Park HJ, Lee PH, Ahn YW et al (2007) Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. Eur J Neurosci 26:79\u201389. https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05636.x","journal-title":"Eur J Neurosci"},{"key":"1359_CR53","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E (2014) Innate immune activation in neurodegenerative disease. Nat Rev Immunol 14:463\u2013477. https:\/\/doi.org\/10.1038\/nri3705","journal-title":"Nat Rev Immunol"},{"key":"1359_CR54","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.bcp.2015.07.032","volume":"97","author":"J Egea","year":"2015","unstructured":"Egea J, Buendia I, Parada E et al (2015) Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection. Biochem Pharmacol 97:463\u2013472. https:\/\/doi.org\/10.1016\/j.bcp.2015.07.032","journal-title":"Biochem Pharmacol"},{"key":"1359_CR55","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-2094-2-4","volume":"2","author":"R De Simone","year":"2005","unstructured":"De Simone R, Ajmone-Cat MA, Carnevale D et al (2005) Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J Neuroinflammation 2:4. https:\/\/doi.org\/10.1186\/1742-2094-2-4","journal-title":"J Neuroinflammation"},{"key":"1359_CR56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jneuroim.2010.09.008","volume":"230","author":"R Benfante","year":"2011","unstructured":"Benfante R, Antonini RA, De Pizzol M et al (2011) Expression of the \u03b17 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS. J Neuroimmunol 230:74\u201384. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.09.008","journal-title":"J Neuroimmunol"},{"key":"1359_CR57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0165-5728(02)00057-7","volume":"126","author":"Y Villiger","year":"2002","unstructured":"Villiger Y, Szanto I, Jaconi S et al (2002) Expression of an alpha7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytes. J Neuroimmunol 126:86\u201398","journal-title":"J Neuroimmunol"},{"key":"1359_CR58","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jneuroim.2019.04.012","volume":"332","author":"A Maroli","year":"2019","unstructured":"Maroli A, Di Lascio S, Drufuca L et al (2019) Effect of donepezil on the expression and responsiveness to LPS of CHRNA7 and CHRFAM7A in macrophages: a possible link to the cholinergic anti-inflammatory pathway. J Neuroimmunol 332:155\u2013166. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.04.012","journal-title":"J Neuroimmunol"},{"key":"1359_CR59","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1093\/hmg\/ddr357","volume":"20","author":"DH Yasui","year":"2011","unstructured":"Yasui DH, Scoles HA, Horike S, Meguro-Horike M, Dunaway KW, Schroeder DI, Lasalle JM (2011) 15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain. Hum Mol Genet 20:4311\u20134323. https:\/\/doi.org\/10.1093\/hmg\/ddr357","journal-title":"Hum Mol Genet"},{"key":"1359_CR60","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1176\/appi.ajp.2015.14080978","volume":"172","author":"Y Kunii","year":"2015","unstructured":"Kunii Y, Zhang W, Xu Q et al (2015) CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders. Am J Psychiatry 172:1122\u20131130. https:\/\/doi.org\/10.1176\/appi.ajp.2015.14080978","journal-title":"Am J Psychiatry"},{"key":"1359_CR61","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1111\/bph.13954","volume":"175","author":"V Mucchietto","year":"2018","unstructured":"Mucchietto V, Fasoli F, Pucci S et al (2018) \u03b19- and \u03b17-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line. Br J Pharmacol 175:1957\u20131972. https:\/\/doi.org\/10.1111\/bph.13954","journal-title":"Br J Pharmacol"},{"key":"1359_CR62","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.bcp.2011.06.018","volume":"82","author":"T Araud","year":"2011","unstructured":"Araud T, Graw S, Berger R et al (2011) The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of \u03b17*nAChR function. Biochem Pharmacol 82:904\u2013914. https:\/\/doi.org\/10.1016\/j.bcp.2011.06.018","journal-title":"Biochem Pharmacol"},{"key":"1359_CR63","doi-asserted-by":"publisher","first-page":"26451","DOI":"10.1074\/jbc.M114.582858","volume":"289","author":"Y Wang","year":"2014","unstructured":"Wang Y, Xiao C, Indersmitten T et al (2014) The duplicated \u03b17 subunits assemble and form functional nicotinic receptors with the full-length \u03b17. J Biol Chem 289:26451\u201326463. https:\/\/doi.org\/10.1074\/jbc.M114.582858","journal-title":"J Biol Chem"},{"key":"1359_CR64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5114\/fn.2013.34198","volume":"51","author":"A Rozycka","year":"2013","unstructured":"Rozycka A, Dorszewska J, Steinborn B et al (2013) A transcript coding for a partially duplicated form of \u03b17 nicotinic acetylcholine receptor is absent from the CD4+ T-lymphocytes of patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). Folia Neuropathol 51:65\u201375","journal-title":"Folia Neuropathol"},{"key":"1359_CR65","doi-asserted-by":"publisher","first-page":"729478","DOI":"10.4061\/2011\/729478","volume":"2011","author":"S Swaminathan","year":"2011","unstructured":"Swaminathan S, Kim S, Shen L et al (2011) Genomic copy number analysis in Alzheimer\u2019s disease and mild cognitive impairment: an ADNI study. Int J Alzheimers Dis 2011:729478. https:\/\/doi.org\/10.4061\/2011\/729478","journal-title":"Int J Alzheimers Dis"},{"key":"1359_CR66","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000230036","volume":"28","author":"A Feh\u00e9r","year":"2009","unstructured":"Feh\u00e9r A, Juh\u00e1sz A, Riman\u00f3czy A et al (2009) Association between a genetic variant of the alpha-7 nicotinic acetylcholine receptor subunit and four types of dementia. Dement Geriatr Cogn Disord 28:56\u201362. https:\/\/doi.org\/10.1159\/000230036","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1359_CR67","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","volume":"80","author":"C Iadecola","year":"2013","unstructured":"Iadecola C (2013) The pathobiology of vascular dementia. Neuron 80:844\u2013866. https:\/\/doi.org\/10.1016\/j.neuron.2013.10.008","journal-title":"Neuron"},{"key":"1359_CR68","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s13365-015-0401-8","volume":"22","author":"FM Ramos","year":"2016","unstructured":"Ramos FM, Delgado-V\u00e9lez M, Ortiz \u00c1 et al (2016) Expression of CHRFAM7A and CHRNA7 in neuronal cells and postmortem brain of HIV-infected patients: considerations for HIV-associated neurocognitive disorder. J Neurovirol 22:327\u2013335. https:\/\/doi.org\/10.1007\/s13365-015-0401-8","journal-title":"J Neurovirol"},{"key":"1359_CR69","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1189\/jlb.4RU0814-381R","volume":"97","author":"TW Costantini","year":"2015","unstructured":"Costantini TW, Dang X, Coimbra R et al (2015) CHRFAM7A, a human-specific and partially duplicated \u03b17-nicotinic acetylcholine receptor gene with the potential to specify a human-specific inflammatory response to injury. J Leukoc Biol 97:247\u2013257. https:\/\/doi.org\/10.1189\/jlb.4RU0814-381R","journal-title":"J Leukoc Biol"},{"key":"1359_CR70","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbacli.2015.12.003","volume":"5","author":"A Baird","year":"2016","unstructured":"Baird A, Coimbra R, Dang X et al (2016) Up-regulation of the human-specific CHRFAM7A gene in inflammatory bowel disease. BBA Clin 5:66\u201371. https:\/\/doi.org\/10.1016\/j.bbacli.2015.12.003","journal-title":"BBA Clin"},{"key":"1359_CR71","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1570159X11311030006","volume":"11","author":"MB Colovic","year":"2013","unstructured":"Colovic MB, Krstic DZ, Lazarevic-Pasti TD et al (2013) Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 11:315\u2013335. https:\/\/doi.org\/10.2174\/1570159X11311030006","journal-title":"Curr Neuropharmacol"},{"key":"1359_CR72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neurobiolaging.2018.09.001","volume":"73","author":"SH Han","year":"2019","unstructured":"Han SH, Park JC, Byun MS et al (2019) Blood acetylcholinesterase level is a potential biomarker for the early detection of cerebral amyloid deposition in cognitively normal individuals. Neurobiol Aging 73:21\u201329. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.09.001","journal-title":"Neurobiol Aging"},{"key":"1359_CR73","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1046\/j.1471-4159.2003.02296.x","volume":"88","author":"LR Fodero","year":"2004","unstructured":"Fodero LR, Mok SS, Losic D et al (2004) Alpha7-nicotinic acetylcholine receptors mediate an Abeta(1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones. J Neurochem 88:1186\u20131193. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.02296.x","journal-title":"J Neurochem"},{"key":"1359_CR74","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1742-4658.2007.06238.x","volume":"275","author":"NC Inestrosa","year":"2008","unstructured":"Inestrosa NC, Dinamarca MC, Alvarez A (2008) Amyloid-cholinesterase interactions. Implications for Alzheimer\u2019s disease. FEBS J 275:625\u2013632. https:\/\/doi.org\/10.1111\/j.1742-4658.2007.06238.x","journal-title":"Implications for Alzheimer\u2019s disease. FEBS J"},{"key":"1359_CR75","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2174\/1567205010666131212113218","volume":"11","author":"M Reale","year":"2014","unstructured":"Reale M, Di Nicola M, Velluto L et al (2014) Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-\u03b2 ex vivo activation of peripheral chemo-cytokines from Alzheimer\u2019s disease subjects: exploring the cholinergic anti-inflammatory pathway. Curr Alzheimer Res 11:608\u2013622","journal-title":"Curr Alzheimer Res"},{"key":"1359_CR76","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3233\/JAD-160074","volume":"52","author":"F Clarelli","year":"2016","unstructured":"Clarelli F, Mascia E, Santangelo R et al (2016) CHRNA7 gene and response to cholinesterase inhibitors in an Italian cohort of Alzheimer\u2019s disease patients. J Alzheimers Dis 52:1203\u20131208. https:\/\/doi.org\/10.3233\/JAD-160074","journal-title":"J Alzheimers Dis"},{"key":"1359_CR77","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/1533317514539540","volume":"30","author":"IL Braga","year":"2015","unstructured":"Braga IL, Silva PN, Furuya TK et al (2015) Effect of APOE and CHRNA7 genotypes on the cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer\u2019s disease. Am J Alzheimers Dis Other Demen 30:139\u2013144. https:\/\/doi.org\/10.1177\/1533317514539540","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"1359_CR78","first-page":"1179","volume":"18","author":"P Russo","year":"2017","unstructured":"Russo P, Kisialiou A, Moroni R et al (2017) Effect of genetic polymorphisms (SNPs) in CHRNA7 gene on response to acetylcholinesterase inhibitors (AChEI) in patients with Alzheimer\u2019s disease. Curr Drug Targets 18:1179\u20131190","journal-title":"Curr Drug Targets"},{"key":"1359_CR79","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neuint.2009.09.011","volume":"56","author":"E Tyagi","year":"2010","unstructured":"Tyagi E, Agrawal R, Nath C et al (2010) Cholinergic protection via alpha7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation. Neurochem Int 56:135\u2013142. https:\/\/doi.org\/10.1016\/j.neuint.2009.09.011","journal-title":"Neurochem Int"},{"key":"1359_CR80","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/jnc.12319","volume":"127","author":"MY Noh","year":"2013","unstructured":"Noh MY, Koh SH, Kim SM et al (2013) Neuroprotective effects of donepezil against Abeta42-induced neuronal toxicity are mediated through not only enhancing PP2A activity but also regulating GSK-3beta and nAChRs activity. J Neurochem 127:562\u2013574. https:\/\/doi.org\/10.1111\/jnc.12319","journal-title":"J Neurochem"},{"key":"1359_CR81","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/ageing\/afl027","volume":"35","author":"N Tabet","year":"2006","unstructured":"Tabet N (2006) Acetylcholinesterase inhibitors for Alzheimer\u2019s disease: anti-inflammatories in acetylcholine clothing! Age Ageing 35:336\u2013338. https:\/\/doi.org\/10.1093\/ageing\/afl027","journal-title":"Age Ageing"},{"key":"1359_CR82","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0028-3908(03)00317-4","volume":"46","author":"E Arias","year":"2004","unstructured":"Arias E, Al\u00e9s E, Gabilan NH et al (2004) Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. Neuropharmacology 46:103\u2013114","journal-title":"Neuropharmacology"},{"key":"1359_CR83","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1111\/bph.14030","volume":"174","author":"SH Kim","year":"2017","unstructured":"Kim SH, Kandiah N, Hsu JL et al (2017) Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer\u2019s disease. Br J Pharmacol 174:4224\u20134232. https:\/\/doi.org\/10.1111\/bph.14030","journal-title":"Br J Pharmacol"},{"key":"1359_CR84","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.brainres.2005.04.014","volume":"1047","author":"M Kimura","year":"2005","unstructured":"Kimura M, Akasofu S, Ogura H et al (2005) Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons. Brain Res 1047:72\u201384. https:\/\/doi.org\/10.1016\/j.brainres.2005.04.014","journal-title":"Brain Res"},{"key":"1359_CR85","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.neuropharm.2005.10.013","volume":"50","author":"E Nizri","year":"2006","unstructured":"Nizri E, Hamra-Amitay Y, Sicsic C et al (2006) Anti-inflammatory properties of cholinergic up-regulation: a new role for acetylcholinesterase inhibitors. Neuropharmacology 50:540\u2013547. https:\/\/doi.org\/10.1016\/j.neuropharm.2005.10.013","journal-title":"Neuropharmacology"},{"key":"1359_CR86","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/ana.20454","volume":"57","author":"Y Pollak","year":"2005","unstructured":"Pollak Y, Gilboa A, Ben-Menachem O et al (2005) Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production. Ann Neurol 57:741\u2013745. https:\/\/doi.org\/10.1002\/ana.20454","journal-title":"Ann Neurol"},{"key":"1359_CR87","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.neuropharm.2005.11.006","volume":"50","author":"M Reale","year":"2006","unstructured":"Reale M, Iarlori C, Gambi F et al (2006) The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer\u2019s disease patients. Neuropharmacology 50:606\u2013613. https:\/\/doi.org\/10.1016\/j.neuropharm.2005.11.006","journal-title":"Neuropharmacology"},{"key":"1359_CR88","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neulet.2010.09.050","volume":"486","author":"E Conti","year":"2010","unstructured":"Conti E, Galimberti G, Tremolizzo L et al (2010) Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1-42 antibodies in Alzheimer\u2019s disease patients. Neurosci Lett 486:193\u2013196. https:\/\/doi.org\/10.1016\/j.neulet.2010.09.050","journal-title":"Neurosci Lett"},{"key":"1359_CR89","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/jnc.13294","volume":"135","author":"O Imamura","year":"2015","unstructured":"Imamura O, Arai M, Dateki M et al (2015) Nicotinic acetylcholine receptors mediate donepezil-induced oligodendrocyte differentiation. J Neurochem 135:1086\u20131098. https:\/\/doi.org\/10.1111\/jnc.13294","journal-title":"J Neurochem"},{"key":"1359_CR90","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3109\/10799893.2010.505239","volume":"30","author":"J Ludwig","year":"2010","unstructured":"Ludwig J, H\u00f6ffle-Maas A, Samochocki M et al (2010) Localization by site-directed mutagenesis of a galantamine binding site on \u03b17 nicotinic acetylcholine receptor extracellular domain. J Recept Signal Transduct Res 30:469\u2013483. https:\/\/doi.org\/10.3109\/10799893.2010.505239","journal-title":"J Recept Signal Transduct Res"},{"key":"1359_CR91","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1124\/jpet.102.045773","volume":"305","author":"M Samochocki","year":"2003","unstructured":"Samochocki M, H\u00f6ffle A, Fehrenbacher A et al (2003) Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. J Pharmacol Exp Ther 305:1024\u20131036. https:\/\/doi.org\/10.1124\/jpet.102.045773","journal-title":"J Pharmacol Exp Ther"},{"key":"1359_CR92","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1111\/bph.14329","volume":"175","author":"NM Kowal","year":"2018","unstructured":"Kowal NM, Ahring PK, Liao VWY et al (2018) Galantamine is not a positive allosteric modulator of human alpha4beta2 or alpha7 nicotinic acetylcholine receptors. Br J Pharmacol 175:2911\u20132925. https:\/\/doi.org\/10.1111\/bph.14329","journal-title":"Br J Pharmacol"},{"key":"1359_CR93","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.brainresbull.2004.06.008","volume":"64","author":"B Giunta","year":"2004","unstructured":"Giunta B, Ehrhart J, Townsend K et al (2004) Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120. Brain Res Bull 64:165\u2013170. https:\/\/doi.org\/10.1016\/j.brainresbull.2004.06.008","journal-title":"Brain Res Bull"},{"key":"1359_CR94","doi-asserted-by":"publisher","first-page":"40180","DOI":"10.1074\/jbc.M110.142356","volume":"285","author":"K Takata","year":"2010","unstructured":"Takata K, Kitamura Y, Saeki M et al (2010) Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors. J Biol Chem 285:40180\u201340191. https:\/\/doi.org\/10.1074\/jbc.M110.142356","journal-title":"J Biol Chem"},{"key":"1359_CR95","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejphar.2005.10.028","volume":"527","author":"T Kume","year":"2005","unstructured":"Kume T, Sugimoto M, Takada Y et al (2005) Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons. Eur J Pharmacol 527:77\u201385. https:\/\/doi.org\/10.1016\/j.ejphar.2005.10.028","journal-title":"Eur J Pharmacol"},{"key":"1359_CR96","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejphar.2008.06.027","volume":"590","author":"Y Takada-Takatori","year":"2008","unstructured":"Takada-Takatori Y, Kume T, Ohgi Y et al (2008) Mechanisms of alpha7-nicotinic receptor up-regulation and sensitization to donepezil induced by chronic donepezil treatment. Eur J Pharmacol 590:150\u2013156. https:\/\/doi.org\/10.1016\/j.ejphar.2008.06.027","journal-title":"Eur J Pharmacol"},{"key":"1359_CR97","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.neuropharm.2010.02.003","volume":"58","author":"J Hwang","year":"2010","unstructured":"Hwang J, Hwang H, Lee HW et al (2010) Microglia signaling as a target of donepezil. Neuropharmacology 58:1122\u20131129. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.02.003","journal-title":"Neuropharmacology"},{"key":"1359_CR98","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejphar.2016.06.053","volume":"789","author":"M Arikawa","year":"2016","unstructured":"Arikawa M, Kakinuma Y, Noguchi T et al (2016) Donepezil, an acetylcholinesterase inhibitor, attenuates LPS-induced inflammatory response in murine macrophage cell line RAW 264.7 through inhibition of nuclear factor kappa B translocation. Eur J Pharmacol 789:17\u201326. https:\/\/doi.org\/10.1016\/j.ejphar.2016.06.053","journal-title":"Eur J Pharmacol"},{"key":"1359_CR99","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/nm1124","volume":"10","author":"H Wang","year":"2004","unstructured":"Wang H, Liao H, Ochani M et al (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10:1216\u20131221. https:\/\/doi.org\/10.1038\/nm1124","journal-title":"Nat Med"},{"key":"1359_CR100","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","volume":"12","author":"R Cacace","year":"2016","unstructured":"Cacace R, Sleegers K, Van Broeckhoven C (2016) Molecular genetics of early-onset Alzheimer\u2019s disease revisited. Alzheimers Dement 12:733\u2013748. https:\/\/doi.org\/10.1016\/j.jalz.2016.01.012","journal-title":"Alzheimers Dement"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-019-01359-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-019-01359-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-019-01359-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T01:34:54Z","timestamp":1619660094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-019-01359-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,3]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1359"],"URL":"https:\/\/doi.org\/10.1007\/s40520-019-01359-4","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,3]]},"assertion":[{"value":"19 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}